Investing in
science & engineering
from the best of Australian Research.
We partner with scientists and engineers with the power to reshape industries and solve the planet’s hardest problems.
%201.avif)
Our Focus
Where we invest.
Human Health
Product and services advancing the standard of health care
Advanced Computing
Next-generation processing and computational systems
Physical World
Addressing the environmental challenges facing our world
Stage
When we invest.
We invest to productise research and bridge the financing gap that exists for TRL 4-7 companies.
We typically write first cheques anywhere from as small as 100k to 500k. Cheque size for us is an indication of conviction.
We typically write first cheques anywhere from as small as 100k to 500k. Cheque size for us is an indication of conviction.
.png)
.png)
Our Process
How we invest.
Meeting #1
IC1 Review
Meeting #2
Due Diligence
IC2 Review
Offer
Uniseed IC
First Meeting
Due Diligence
IC Decision
Offer
Our Portfolio
Highlights
Kinoxis
Developing next generation therapeutics for behavioural and cognitive disorders.
Neurode
Personalised brain stimulation to boost focus and cognitivefunction.
BioScout
Preventing airborne diseases in agriculture with cutting-edge technology that helps farmers proactively manage crops.
Partnered With
Australia’s first University Fund.
10 of the top research institutions in Australia
20 years experience in commercialisation
Leading superannuation fund Unisuper
+23
Who we are
Multidisciplinary team.
Decades of experience in building, scaling and fundraising with a deep network people ready to roll up their sleeves.
Get In Touch
Harikesh Pushpapathan
Partner
Guy Hedley
Co-Founder & Partner
Dr Geoff Waring
Co-founder and Venture Partner
Safaa Nasrallah
Investments & Operations
Diego Gourgues
Chief Financial Officer
.webp)
Location
1 Macquarie Pl, Sydney NSW 2000
Operating hours
Monday to Friday, 9:00 AM - 5:00 PM
